Featured Story | By Nick Paul Taylor The FDA has approved an injectable version of Johnson & Johnson’s pulmonary arterial hypertension drug Uptravi. J&J developed the formulation to allow patients to continue to receive treatment if they are temporarily unable to take the oral version of the drug. read more |
| |
|---|
|
Top Stories By Nick Paul Taylor Boehringer Ingelheim has struck a deal to apply Nanoform's nanoparticle technology to its preclinical pipeline prospects. The master services agreement positions the partners to work to improve the solubility and bioavailability of drug candidates in development at Boehringer. read more By Nick Paul Taylor Aptar has struck a deal to buy an 80% stake in Chinese injectable drug delivery player Weihai Hengyu Medical Products. The acquisition gives Aptar a chance to access the major market even if China tries to limit its reliance on imports from overseas. read more By Nick Paul Taylor Atai Life Sciences has created a startup to develop a nose-to-brain delivery system for the treatment of mental health disorders. The startup, InnarisBio, has secured exclusive rights to a sol-gel nasal drug delivery platform in certain fields. read more By Kyle LaHucik Ipsen is digging deeper into neuroscience, with a $20 million upfront payment to Exicure in a discovery deal for up to two preclinical assets in Huntington's disease and Angelman syndrome. The agreement is back loaded with up to $1 billion in fees and focuses on two rare genetic disorders. read more Resources Sponsored by: Patheon by Thermo Fisher Scientific Learn how regulations are changing and key considerations for commercializing cell and gene therapies without sacrificing quality. Sponsored by: LabVantage Solutions Uncover the real impact of “digital transformation” with practical advice to help you plan your own transformative journey to a harmonized digital ecosystem. Sponsored by: Box Read Get to Know Cloud Content Management for Life Sciences and learn how to eliminate silos across all workflows, from R&D to commercialization. Sponsored by: Cytiva A one-stop hub for Cytiva resources to support process intesification Sponsored by: Cytiva A one-stop hub for Cytiva resources to support process development and manufacturing of your novel molecule Sponsored By: Remarque Systems Remarque Systems consolidates data, then layers on visualization and automated metrics to generate consistent, actionable data insights in real-time. Click here for more info. Sponsored By: Within3 We enable virtual work — offering over-time sessions where participants are more focused, insights are more diverse and business goals are met. Sponsored by: Catalent Discover the current state of patient-focused dose design through clinical evidence, real-world case studies and patient preference-driven drug design solutions that can help develop better treatments and successful real-world outcomes. Sponsored by: Catalent This eBook features insights from experts in the industry on patient-centric drug development challenges and strategies on advancing drug design and development effectively. Sponsored by: Catalent Learn about drug product process development challenges and risks, the difference between innovator and biosimilar drug product process development, and more during the drug product process development phase. | 
